We provide products and services to ophthalmologists. Helping to restore sight compromised by cataracts is our Singular Focus.Read More
Our mission is to provide innovative devices and services in key strategic segments to help you elevate your quality of care and business efficiencies.Read More
HOYA Surgical Optics is different. We’re Globally Powered, a leading ophthalmic device company with a strong entrepreneurial spirit and a dedication to improving both patient outcomes and practice results.Read More
HOYA to invest in InnFocus, Inc., a new glaucoma device company. InnFocus also announced that it received authorization from the FDA to begin Phase I trial of the InnFocus MicroShunt™ to treat open angle glaucoma.
HOYA Surgical Optics announced that it has completed the installation and validation of new equipment at its factory in Singapore and resumed manufacturing of the 1-Piece IOLs that were voluntarily recalled.
HOYA Surgical Optics announced a voluntary recall of NY-60, iSert® 250, iSert® 251, Toric 311, and iSert® Toric 351 IOLs
HOYA Surgical Optics, Inc. (HSO) announced today that they have received approval from the FDA to commercially distribute two models of clear foldable hydrophobic acrylic‐optic aspheric intraocular lenses; the iSymm™ Intraocular Lens (Model FC‐60AD) and the preloaded iSert™ Intraocular Lens (Model PC‐60AD) in the U.S.
HOYA Surgical Optics and Tracey Technologies, Inc. announced the introduction of a new system for cataract surgeons that incorporates the latest version of the proven HOYA iSert® aspheric hydrophobic IOL together with the most advanced iTrace™ system ever developed, the HOYA iTrace™ Surgical Workstation.
HOYA Surgical Optics announced record results for their business in 2010 and a global optimization plan for 2011. The 2010 business results were achieved based on growth of their intraocular lens business in all sales regions: Japan, Asia/Pacific, the Americas, and EMEA. The new globalization plan that begins this month will result in a realignment of functions and departments and a move of the company’s headquarters to Singapore.
The iSert™ Preloaded IOL Injection System provides predictable and safe insertion of glistening-free hydrophobic acrylic aspheric IOLs through a sub 2.4 mm incision.
HOYA Surgical Optics today announced that the Centers for Medicare and Medicaid Services (CMS) has added the Blue Light Absorbing iSymm Aspheric Lens from Hoya Surgical Optics to the New Technology Intraocular Lens (NTIOL) class for IOLs with Reduced Spherical Aberration.
The NTIOL designation indicates that the iSymm lens has been proven to provide subset-specific clinical benefits and is approved for $50 additional Medicare payment in conjunction with cataract procedures performed in ambulatory surgical centers under the HCPCS code Q1003.
Hoya Corporation announced the appointment of Thomas A. Dunlap, MBA, to the position of Global President and Chief Executive Officer, Hoya Surgical Optics, Inc. (HSO).
Hoya Surgical Optics, Inc. Plans to Begin USA Distribution in late 2008
HOYA Surgical Optics is proud to hold its second annual Scientific Awards competition, recognizing good science and providing young Austrian surgeons with further experience in presenting information to scientists.
The winners of the First Annual HOYA Surgical Optics Scientific Prize were announced in May during the ÖOG in Bad Ischl, Austria.
On May 14th, the Grand Auditorium of the Palais de Congrès in Paris hosted an awards ceremony for the winners of the recent SFO HOYA Poster Competition.
HOYA Surgical Optics announced that it has received higher than expected reported rates of inflammation and/or endophthalmitis from doctors using iSert® 250, iSert® 251, and NY-60 IOLs in a few countries.
Pharmaceutical Executive magazine’s January 2013 issue includes a country report for Singapore and features remarks by Thomas A. Dunlap, President & CEO of HOYA Surgical Optics.
HOYA Surgical Optics announced today the opening of its new global headquarters in Singapore. In an open house launch event at the new headquarters attended by ophthalmologists, business partners, and local officials, Thomas A. Dunlap, President and CEO of HOYA Surgical Optics, said: “Our business has grown rapidly and become more globally integrated.”